The impact of APOE on myocardial infarction, stroke, and dementia: the Rotterdam Study

A J C Slooter, M Cruts, A Hofman, P J Koudstaal, D van der Kuip, M A J de Ridder, J C M Witteman, M M B Breteler, C Van Broeckhoven, C M van Duijn

Research output: Contribution to journalArticlepeer-review

45 Citations (Scopus)

Abstract

It is unclear how the APOE genotype contributes to the incidence of vascular diseases and dementia. In a population-based sample (n = 6,852) with complete follow-up, APOE was weakly associated with myocardial infarction and not related with stroke. In the absence of epsilon4, the incidence of dementia would be 25.8% lower; in the absence of epsilon2/epsilon3, 2.8% higher. Risk estimates of dementia, specified for age, sex, and APOE, are provided for counseling. APOE is not strongly related to vascular diseases, but contributes substantially to dementia incidence.

Original languageEnglish
Pages (from-to)1196-1198
Number of pages3
JournalNeurology
Volume62
Issue number7
DOIs
Publication statusPublished - 13 Apr 2004

Keywords

  • Age Distribution
  • Aged
  • Apolipoproteins E/genetics
  • Cohort Studies
  • Dementia/epidemiology
  • Female
  • Genotype
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Myocardial Infarction/epidemiology
  • Netherlands/epidemiology
  • Proportional Hazards Models
  • Risk
  • Risk Assessment
  • Sex Distribution
  • Stroke/epidemiology
  • Whites/genetics

Fingerprint

Dive into the research topics of 'The impact of APOE on myocardial infarction, stroke, and dementia: the Rotterdam Study'. Together they form a unique fingerprint.

Cite this